ATE413861T1 - Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben - Google Patents

Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben

Info

Publication number
ATE413861T1
ATE413861T1 AT02768363T AT02768363T ATE413861T1 AT E413861 T1 ATE413861 T1 AT E413861T1 AT 02768363 T AT02768363 T AT 02768363T AT 02768363 T AT02768363 T AT 02768363T AT E413861 T1 ATE413861 T1 AT E413861T1
Authority
AT
Austria
Prior art keywords
castor oil
lipid
hydrogenated castor
pharmaceutically elegant
oil dispersed
Prior art date
Application number
AT02768363T
Other languages
English (en)
Inventor
David Jones
David Hobson
Pilar Duque
Original Assignee
Healthpoint Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthpoint Ltd filed Critical Healthpoint Ltd
Application granted granted Critical
Publication of ATE413861T1 publication Critical patent/ATE413861T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02768363T 2001-09-04 2002-07-29 Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben ATE413861T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/945,903 US6479060B1 (en) 2001-09-04 2001-09-04 Elegant hydrogenated castor oil ointments

Publications (1)

Publication Number Publication Date
ATE413861T1 true ATE413861T1 (de) 2008-11-15

Family

ID=25483673

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02768363T ATE413861T1 (de) 2001-09-04 2002-07-29 Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben

Country Status (15)

Country Link
US (1) US6479060B1 (de)
EP (1) EP1423154B1 (de)
JP (1) JP4115391B2 (de)
KR (2) KR100764278B1 (de)
CN (1) CN100463697C (de)
AT (1) ATE413861T1 (de)
AU (1) AU2002330929B2 (de)
BR (1) BR0212286A (de)
CA (1) CA2459239C (de)
DE (1) DE60229855D1 (de)
DK (1) DK1423154T3 (de)
ES (1) ES2315400T3 (de)
MX (1) MXPA04001969A (de)
PT (1) PT1423154E (de)
WO (1) WO2003020203A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
US20050048105A1 (en) * 2003-08-29 2005-03-03 Mcnulty Amy K. Protease inhibitor compositions for prevention and treatment of skin conditions
US20050100621A1 (en) * 2003-11-07 2005-05-12 Popp Karl F. Dermatological compositions
US20060264505A1 (en) * 2003-11-07 2006-11-23 Stiefel Laboratories, Inc. Dermatological compositions
US20050281806A1 (en) * 2004-06-16 2005-12-22 Collegium Pharmaceutical, Inc., Delaware Compositions for topical enzymatic debridement
US8211449B2 (en) * 2004-06-24 2012-07-03 Dpt Laboratories, Ltd. Pharmaceutically elegant, topical anhydrous aerosol foam
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
AR065378A1 (es) * 2007-02-16 2009-06-03 Procter & Gamble Articulo absorbente con locion que comprende un material de polipropilenglicol
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
WO2009090495A2 (en) 2007-12-07 2009-07-23 Foamix Ltd. Oil and liquid silicone foamable carriers and formulations
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
KR101102857B1 (ko) * 2009-08-07 2012-01-10 남연우 주방용기
EP2482788B1 (de) 2009-10-02 2022-12-14 Journey Medical Corporation Topische tetracyclinzusammensetzungen
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
KR20120117995A (ko) 2009-12-08 2012-10-25 헬쓰포인트, 엘티디. 강화된 효소 활성을 갖는 효소적 창상 괴사조직제거 조성물
US20130053353A1 (en) * 2010-05-04 2013-02-28 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses
US9011931B1 (en) 2011-01-26 2015-04-21 Libby Robinson Wound dressing composition and method of use
KR102058756B1 (ko) * 2011-02-15 2020-01-22 어클라리스 쎄라퓨틱스, 인코포레이티드 주사비 징후들의 치료용 옥시메타졸린의 약학 크림 조성물들
US20140154235A1 (en) 2011-05-12 2014-06-05 Smith & Nephew Orthopaedics Ag Wound debridement compositions containing seaprose and methods of wound treatment using same
RU2014145270A (ru) 2012-05-11 2016-07-10 Смит & Невью, Инк. Способ и композиция для разрушения бактериальной биопленки
US11628207B2 (en) 2016-07-27 2023-04-18 Smith & Nephew, Inc. Use of thermolysin to reduce or eliminate bacterial biofilms from surfaces
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
WO2018140707A1 (en) 2017-01-30 2018-08-02 Smith & Nephew, Inc. Synergistic combination of thermolysin and an antibacterial agent to reduce eliminate bacterial biofilms from surfaces
US12029809B2 (en) * 2021-06-10 2024-07-09 Pauleine Prospere Hair or skin treatment composition and methods of preparation and use

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB892450A (en) * 1959-11-18 1962-03-28 Ici Ltd Improvements in or relating to pharmaceutical compositions comprising ethylthiocarbonyl compounds
US3314972A (en) * 1965-05-21 1967-04-18 Warner Lambert Pharmaceutical Indolo[3, 2-c]thiopyrylium compounds and intermediates therefor
US5021429A (en) * 1977-05-17 1991-06-04 Allen & Hansburys Limited Pharmacologically active aminoalkylphenyl compounds and their use
JPS546002A (en) * 1977-06-17 1979-01-17 Chuo Yuka Lithium soappbase lubricating grease compositions and production thereof
DE2924005C2 (de) 1979-06-13 1984-07-05 Sanol Schwarz-Monheim Gmbh, 4019 Monheim Isosorbiddinitrat enthaltendes Mittel
NZ196700A (en) 1980-04-18 1983-04-12 Smith & Nephew Ass Anti-inflammatory compositions containing 5-benzoyl-1-methylpyrrole-2-acetic acid derivatives
US4334546A (en) * 1980-09-08 1982-06-15 Kolmar Laboratories Inc. Cosmetic pencil
US5102656A (en) 1983-07-29 1992-04-07 The Mennen Company Antiperspirant creams
DE3409720A1 (de) * 1984-03-16 1985-09-19 Bayer Ag, 5090 Leverkusen Strukturviskos eingestellte silikonpasten und deren verwendung als abformmassen
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
IT1183530B (it) * 1985-03-29 1987-10-22 Monteluos S P A Composizioni per cosmesi comprendente perfluoropolieteri
IT1197056B (it) * 1986-08-01 1988-11-25 Intercos Italiana Pomata per mascherare difetti della pelle e cicatrici
EP0399432B1 (de) 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermales therapeutisches Mittel
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
KR100339793B1 (ko) 1994-10-05 2002-07-18 미사글리아 엠. 외용항염증제
US5869088A (en) 1994-10-24 1999-02-09 Nikken Chemicals Co., Ltd Transdermal administration preparation of a 9-aminocyclopenta (b) quinoline
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
JP4010574B2 (ja) 1994-12-05 2007-11-21 電気化学工業株式会社 皮膚外用剤
RO113156B1 (ro) * 1995-03-10 1998-04-30 Icerp Sa UNSOARE DE LITIU Șl PROCEDEU DE OBȚINERE A ACESTEIA
US6063762A (en) 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US6267970B1 (en) * 1998-03-23 2001-07-31 Avon Products, Inc. Cream cosmetic base with powdery feel
IT1302275B1 (it) * 1998-09-25 2000-09-05 Giorgio Panin Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
US6262117B1 (en) * 1999-02-18 2001-07-17 Allergan Sales, Inc. Method and composition for treating acne

Also Published As

Publication number Publication date
HK1065963A1 (en) 2005-03-11
CN1610563A (zh) 2005-04-27
KR20060086460A (ko) 2006-07-31
EP1423154A2 (de) 2004-06-02
AU2002330929B2 (en) 2005-06-16
CA2459239A1 (en) 2003-03-13
MXPA04001969A (es) 2004-07-08
EP1423154B1 (de) 2008-11-12
CA2459239C (en) 2005-06-14
BR0212286A (pt) 2006-05-23
KR20040041597A (ko) 2004-05-17
US6479060B1 (en) 2002-11-12
WO2003020203A2 (en) 2003-03-13
KR100764278B1 (ko) 2007-10-05
CN100463697C (zh) 2009-02-25
EP1423154A4 (de) 2007-08-15
JP2005527468A (ja) 2005-09-15
JP4115391B2 (ja) 2008-07-09
DE60229855D1 (de) 2008-12-24
DK1423154T3 (da) 2009-01-26
WO2003020203A3 (en) 2003-07-10
KR100638417B1 (ko) 2006-10-24
ES2315400T3 (es) 2009-04-01
PT1423154E (pt) 2009-01-30

Similar Documents

Publication Publication Date Title
DE60229855D1 (de) Hydriertes rizinusöl dispergiert in einem lipid für pharmazeutisch elegante topische salben
PT977562E (pt) Metodos e composicoes para administracao de taxanos
MY144477A (en) Galenic formulations of organic compounds
ES2157307T3 (es) Composicion topica que contiene un antagonista de sustancia p.
IT1302275B1 (it) Formulazione di gel idrofobo a base di vitamina e acetato perapplicazione topica.
IL195892A (en) Pre-concentrates in the form of micro-emulsions of new cyclospores analogues
TW200626132A (en) Topical nepafenac formulations
AU3287200A (en) Composition comprising isoquercetin and ascorbic acid in a sustained release form
BG109876A (en) APPLICATION OF L-CARNITIN ESTERS OR ALCANAILIC L-CARNITINES AS CATIONARY LIPIDS FOR INTRACULAR TRANSMISSION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES
NO20052490D0 (no) Dagsdoseringsenheter for melatonin.
IT1263840B (it) Formulazioni orali di ubidecarenone in forma di capsule
CY1108975T1 (el) Παρασιτοκτονα συνθεση
PT1414467E (pt) Tratamento topico da mastalgia
EP1269991A3 (de) Topische Zusammensetzung die Ethyllinoleat und/oder Triethylzitrat mit Synergisten
HRP20100513T1 (hr) Višefazni kontracepcijski pripravak zasnovan na prirodnom estrogenu
HRP20020258B1 (hr) Farmaceutska kombinacija etinilestradiola i drospirenona za upotrebu kao kontracepcijskog sredstva
BG106368A (en) Pharmaceutical composition and its preparation
IL179544A0 (en) Compositions comprising flavonoids and tocotrienols and methods thereof
PT938339E (pt) Formulacoes para utilizacao topica
Groenendaal–van de Meent et al. YM150, an oral direct inhibitor of factor Xa, demonstrated a predictable and dose-proportional pharmacokinetic/pharmacodynamic profile after single and multiple dosing: results from three studies
ATE340588T1 (de) Pharmazeutische zusammensetzung enthaltend träger für pharmakologisch aktive produkte wobei die träger auf vitamin e, papain und hyaluronidase basieren
BR0001144B1 (pt) Composicão farmacêutica de diclofenaco à base de vitamina-e, papaína e hialuronidase
FR2978661B1 (fr) Composition lipidique pour application cosmetique
AR039604A1 (es) Utilizacion de una sal de acido l-ascorbico para la preparacion de una composicion farmaceutica, para uso oftalmico topico, capaz de mejorar el nivel de acido l-ascorbico en el ojo
EP0792635A3 (de) Antitranspirant Präparat

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1423154

Country of ref document: EP